The anti-tumor effects of an adenoviral vaccine expressing 4-1BB ligand in a murine melanoma model

被引:0
|
作者
Ragonnaud, E. [1 ]
Andersson, A. [1 ]
Jensen, B. A. H. [1 ]
Thomsen, A. R. [1 ]
Holst, P. J. [1 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:723 / 723
页数:1
相关论文
共 50 条
  • [1] Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15
    Shannon L. McArdel
    Anne-Sophie Dugast
    Maegan E. Hoover
    Arjun Bollampalli
    Enping Hong
    Zafira Castano
    Shannon Curtis Leonard
    Sneha Pawar
    Jennifer Mellen
    Kelvin Muriuki
    Douglas C. McLaughlin
    Nicholas Bayhi
    Christopher L. Carpenter
    Laurence A. Turka
    Thomas J. Wickham
    Sivan Elloul
    Cancer Immunology, Immunotherapy, 2021, 70 : 2701 - 2719
  • [2] Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15
    McArdel, Shannon L.
    Dugast, Anne-Sophie
    Hoover, Maegan E.
    Bollampalli, Arjun
    Hong, Enping
    Castano, Zafira
    Leonard, Shannon Curtis
    Pawar, Sneha
    Mellen, Jennifer
    Muriuki, Kelvin
    McLaughlin, Douglas C.
    Bayhi, Nicholas
    Carpenter, Christopher L.
    Turka, Laurence A.
    Wickham, Thomas J.
    Elloul, Sivan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2701 - 2719
  • [3] Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells
    Futagawa, T
    Akiba, H
    Kodama, T
    Takeda, K
    Hosoda, Y
    Yagita, H
    Okumura, K
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (03) : 275 - 286
  • [4] DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model
    Zhang, Haihong
    Wang, Yuqian
    Liu, Chenlu
    Zhang, Lixing
    Xia, Qiu
    Zhang, Yong
    Wu, Jiaxin
    Jiang, Chunlai
    Chen, Yan
    Wu, Yongge
    Zha, Xiao
    Yu, Xianghui
    Kong, Wei
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (10) : 1857 - 1867
  • [5] DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model
    Haihong Zhang
    Yuqian Wang
    Chenlu Liu
    Lixing Zhang
    Qiu Xia
    Yong Zhang
    Jiaxin Wu
    Chunlai Jiang
    Yan Chen
    Yongge Wu
    Xiao Zha
    Xianghui Yu
    Wei Kong
    Cancer Immunology, Immunotherapy, 2012, 61 : 1857 - 1867
  • [6] Targeting 4-1BB in tumors enhances anti-tumor immune responses
    Weber, Amy Mackay
    Innamarato, Patrick
    Morse, Jennifer
    Kidd, Scott
    Asby, Sarah
    Sarnaik, Amod
    Pilon-Thomas, Shari
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Development of 4-1BB agonists: Ligand fusion shows greater anti-tumor activity than antibodies in vivo
    Tam, Eric
    Craig, Galina
    Ghassemifar, Sara
    Koshkaryev, Alexander
    Movassaghian, Sara
    Cosgrove, Cormac
    Sampson, James
    Drummond, Daryl
    Raue, Andreas
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Anti-tumor properties of epitope-specific vaccine in murine model of melanoma
    Stoyanova, Emiliya
    Mihaylova, Nikolina
    Manoylov, Iliyan
    Idakieva, Krassimira
    Tchorbanov, Andrey
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 119 - 119
  • [9] 4-1BB ligation following peptide immunization amplifies an anti-tumor CTL response
    Wilcox, RA
    Tamada, K
    Chapoval, AI
    Sica, G
    Flies, D
    Johnson, A
    Pease, LR
    Chen, L
    FASEB JOURNAL, 2000, 14 (06): : A1004 - A1004
  • [10] 4-1BB Transduced Human T Cells Demonstrate an Improved Anti-Tumor Activity
    Daniel-Meshulam, I.
    Cohen, C. J.
    HUMAN GENE THERAPY, 2009, 20 (05) : 542 - 542